In Re Emergent Biosolutions Inc. Stockholder Derivative Litigation
Case Number:
8:21-cv-01595
Court:
Nature of Suit:
Multi Party Litigation:
Derivative Litigation
Judge:
Firms
- Arnold & Porter
- Dorsey & Whitney
- Miles & Stockbridge
- Miller & Chevalier
- Robbins LLP
- Tydings & Rosenberg
- WilmerHale
Companies
Sectors & Industries:
-
August 07, 2025
BioPharma Co.'s $15M Deal Over Ruined J&J Vaccines OK'd
A Maryland federal judge on Thursday granted final approval to a $15 million settlement to close out a stockholder derivative suit claiming Emergent BioSolutions Inc. and its top brass made a mint selling stock before their allegedly lax oversight led to the contamination of over 15 million Johnson & Johnson COVID-19 vaccine doses.
-
June 30, 2021
Pension Fund Sues BioPharma Board Over COVID Vax Fiasco
An Illinois pension fund slapped top directors at Emergent BioSolutions Inc. with a derivative suit claiming board members made a mint selling stock before their lax oversight led to the contamination of over 15 million Johnson & Johnson COVID-19 vaccine doses.